NecroX-7（Cat No.:I043473）is a small molecule compound that acts as an inhibitor of necroptosis, a form of programmed cell death linked to various diseases, including neurodegeneration, inflammation, and cancer. By blocking key signaling molecules involved in necroptotic cell death, NecroX-7 helps reduce cellular damage and tissue inflammation. It has shown promise in preclinical studies as a potential therapeutic for conditions driven by excessive necroptosis, including ischemic injury and inflammatory diseases. Its ability to modulate cell death pathways positions NecroX-7 as a potential candidate for drug development in treating these diseases.